Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¼¼±âÁ¶Àý¹æ»ç¼±Ä¡·á(IMRT) ȯÀÚÀÇ QA Quality Assurance of Patients for Intensity Modulated Radiation Therapy

´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö 2002³â 20±Ç 1È£ p.81 ~ 90
¼Ò¼Ó »ó¼¼Á¤º¸
À±»ó¹Î/Sang Min Yoon À̺´¿ë/ÃÖÀº°æ/±èÁ¾ÈÆ/¾È½Âµµ/ÀÌ»ó¿í/Byong Yong Yi/Eun Kyung Choi/Jong Hoon Kim/Seung Do Ahn/Sang Wook Lee

Abstract

¸ñÀû: ¼¼±âÁ¶Àý ¹æ»ç¼±Ä¡·á(IMRT) ȯÀÚ¿¡ ÀûÇÕÇÑ Quality Assurance (QA) Ç׸ñÀ» ã¾Æ³»°í Æò°¡ Ç׸ñÀÇ À¯¿ë¼º ¹× Ÿ´ç¼ºÀ» °ËÅäÇÏ¿´´Ù. ´ë»ó ¹× ¹æ¹ý: 3´Ü°è, 16Ç׸ñÀ¸·Î ±¸¼ºµÈ IMRT ȯÀÚ QA programÀ» ¸¸µé¾î 9ȯÀÚ 12¿¹ÀÇ ´Ù¾çÇÑ IMRT ȯÀÚ¿¡
´ëÇØ
Àû¿ëÇÏ°í ±× ¹æ¹ýÀÇ Å¸´ç¼ºÀ» °ËÅäÇÏ¿´´Ù. 3´Ü°è QA Ç׸ñÀº Àü»êÈ­Ä¡·á°èȹ½Ã½ºÅÛ(RTP) QA, Ä¡·á Á¤º¸ÀÇ Àü´Þ QA, Ä¡·á Àü´Þ °úÁ¤ QA µîÀ¸·Î ±¸¼ºµÇ¾ú´Ù. RTP QA´Â ´Ù½Ã organ constraintÀÇ °ËÅä, ±×¸®°í Á¡¼±·® ¹× ¼±·® ºÐÆ÷ÀÇ Å¸´ç¼º Æò°¡ µîÀ¸·Î ¼¼ºÐÈ­ÇÏ¿´´Ù.
Ä¡·á
Á¤º¸ÀÇ Àü´Þ QA¿¡¼­´Â leaf sequence pattern ÀÛ¼º, Ä¡·á Àü´Þ¿ë MLC file »ý¼º ÇÁ·Î±×·¥¿¡¼­ ÀÛ¼ºµÈ IMRT field ¿ë MLC fileÀÇ Á¤È®¼ºÀÇ Æò°¡¿Í ÀÌ file·Î ¸¸µç Ä¡·á Á¶»ç¸éÀÇ dry run °á°ú¸¦ MLC simulation image¿Í ºñ±³ÇÏ¿´´Ù. Ä¡·á Àü´Þ °úÁ¤ QA´Â ȯÀÚÀÇ
set-up
QA¿Í
IMRT field deliveryÀÇ È®ÀÎ, Record and Verify ½Ã½ºÅÛÀÇ È®ÀÎ µîÀ¸·Î ³ª´©¾î ½Ç½ÃÇÏ¿´´Ù. °á°ú: Á¡¼±·® Æò°¡ °á°ú, ÃÑ 12¿¹ Áß 10¿¹¿¡¼­ ÃøÁ¤°ª°ú RTP °è»ê°ªÀÌ 3% À̳»ÀÇ ÀÏÄ¡¸¦ º¸¿´°í, 3% ÀÌ»ó ¹× 5% ÀÌ»óÀÌ °¢°¢ 1¿¹¾¿ ¹ß°ßµÇ¾ú´Ù. RTP¿¡¼­ ¼³°èÇÑ MLC
leaf
À§Ä¡¿Í Dry run¿¡¼­ ³ªÅ¸³­ ½ÇÁ¦ MLC leaf À§Ä¡¸¦ ºñ±³ÇÏ¿´À» ¶§, 2 §® ÀÌ»óÀÇ Â÷À̸¦ º¸ÀÌ´Â ¿¹´Â ¾ø¾ú´Ù. Çʸ§¿¡ ÀÇÇÑ ¼±·® ºÐÆ÷´Â Ä¡·á °èȹ ¼±·® ºÐÆ÷¿Í Á¤¼ºÀûÀ¸·Î ÀÏÄ¡ÇÔÀ» ¾Ë ¼ö ÀÖ¾úÀ¸³ª, Çʸ§ÀÇ Æ¯¼º»ó Á¤·®ÀûÀÎ ºñ±³¸¦ ÇÒ ¼ö´Â ¾ø¾ú´Ù. Leaf sequence¿¡¼­
MLC
fileÀ» »ý¼ºÇÏ´Â ÇÁ·Î±×·¥Àº ¿ÀÂ÷ ¾øÀÌ ±¸µ¿ÇÏ¿´´Ù. °á·Ð: º»¿ø¿¡¼­ ½Ç½ÃÇÑ IMRT ȯÀÚ QA programÀÌ À¯¿ëÇÏ°í ÇÊ¿äÇÑ Ç׸ñÀÓÀ» º¸ÀÏ ¼ö ÀÖ¾ú´Ù. ƯÈ÷ óÀ½ IMRT¸¦ ½ÃÀÛÇÒ ¶§´Â Á¦½ÃµÈ ¸ðµç Ç׸ñ¿¡ ´ëÇÑ QA¸¦ ½Ç½ÃÇÏ¿©¾ß Çϳª °è¼Ó ÀÌ programÀ» À¯ÁöÇϱ⿡´Â
ÀýÂ÷°¡
º¹ÀâÇÏ°í ±ä ½Ã°£ÀÌ ¼Ò¿äµÇ´Â °úÁ¤À̶ó´Â ¹®Á¦°¡ ÀÖ´Ù. Áö¼ÓÀûÀ¸·Î IMRT¸¦ ½Ç½ÃÇÏ´Â ±â°üÀ» À§ÇØ ½Ç¿ëÀûÀ̸ç ÇʼöÀûÀÎ QA Ç׸ñÀ» Á¦½ÃÇÒ ¼ö ÀÖ¾ú´Ù.

Purpose: To establish and verify the proper and the practical IMRT (Intensity-modulated radiation therapy) patient QA (Quality Assurance). Materials and Methods: An IMRT QA which consists of 3 steps and 16 items were designed and
examined
the validity of the program by applying to 9 patients, 12 IMRT cases of various sites. The three step QA program consists of RTP related QA, treatment information flow QA, and a treatment delivery QA procedure. The evaluation of organ
constraints,
the
validity of the point dose, and the dose distribution are major issues in the RTP related QA procedure. The leaf sequence file generation, the evaluation of the MLC control file, the comparison of the dry run film, and the IMRT field simulate
image
were
included in the treatment information flow procedure QA. The patient setup QA, the verification of the IMRT treatment fields to the patients, and the examination of the data in the Record & Verify system make up the treatment delivery QA
procedure.
Results: The point dose measurement results of 10 cases showed good agreement with the RTP calculation within 3%. One case showed more than a 3% difference and the other case showed more than 5%, which was out side the tolerance level. We
could
not find any differences of more than 2 §® between the RTP leaf sequence and the dry run film. Film dosimetry and the dose distribution from the phantom plan showed the same tendency, but quantitative analysis was not possible because of the film
dosimetry nature. No error had been found from the MLC control file and one mis-registration case was found before treatment. Conclusion: This study shows the usefulness and the necessity of the IMRT patient QA program. The whole procedure
of
this program should be performed, especially by institutions that have just started to accumulate experience. But, the program is too complex and time consuming. Therefore, we propose practical and essential QA items for institutions in which the
IMRT
is performed as a routine procedure.

Å°¿öµå

¼¼±âÁ¶Àý¹æ»ç¼±Ä¡·á(IMRT); QA (Quality Assurance); Intensity modulated radiation therapy; Quality assurance;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS